Literature DB >> 16020952

Myocilin gene expression in the trabecular meshwork of rats in a steroid-induced ocular hypertension model.

Keiko Sawaguchi1, Yoshimi Nakamura, Yuko Nakamura, Hiroshi Sakai, Shoichi Sawaguchi.   

Abstract

PURPOSE: To investigate the expression pattern of myocilin in the trabecular meshwork of normal and dexamethasone-induced ocular hypertensive rat eyes.
MATERIALS AND METHODS: An ocular hypertension model was generated by application of topical dexamethasone to rat eyes 4 times daily for 1, 2, and 4 weeks. Age-matched untreated eyes served as controls. The intraocular pressure (IOP) was monitored by electronic Tono-pen under anesthesia. The protein and mRNA levels of myocilin in the trabecular meshwork and endothelial lining of Schlemm's canal were investigated by immunohistochemistry and in situ hybridization, respectively. For semiquantitative evaluation, areas with positive staining were analyzed by a computer-assisted image-processing system with NIH software.
RESULTS: The IOP in rat eyes was elevated after 2 weeks of topical dexamethasone treatment. Despite the IOP elevation, the protein and mRNA levels of myocilin in the trabecular meshwork and around Schlemm's canal in the steroid-treated eyes were not different from those of controls.
CONCLUSION: No discernible changes in myocilin expression in the chamber angle indicate that myocilin may not be directly linked to ocular hypertension, at least not in rat eyes after relatively short-term steroid application.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16020952     DOI: 10.1159/000086946

Source DB:  PubMed          Journal:  Ophthalmic Res        ISSN: 0030-3747            Impact factor:   2.892


  21 in total

Review 1.  Glaucoma-associated myocilin: a better understanding but much more to learn.

Authors:  Zachary T Resch; Michael P Fautsch
Journal:  Exp Eye Res       Date:  2008-08-29       Impact factor: 3.467

Review 2.  Role of the alternatively spliced glucocorticoid receptor isoform GRβ in steroid responsiveness and glaucoma.

Authors:  Ankur Jain; Robert J Wordinger; Thomas Yorio; Abbot F Clark
Journal:  J Ocul Pharmacol Ther       Date:  2014-02-07       Impact factor: 2.671

Review 3.  Inducible rodent models of glaucoma.

Authors:  Iok-Hou Pang; Abbot F Clark
Journal:  Prog Retin Eye Res       Date:  2019-09-23       Impact factor: 21.198

4.  Intravitreal triamcinolone acetonide induced changes in the anterior segment in a pig model of branch retinal vein occlusion.

Authors:  Sarojini Vijayasekaran; Ian L McAllister; William H Morgan; Kanishka R Mendis; Paul G McMenamin; Stephen J Cringle; Dao-Yi Yu
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-07-23       Impact factor: 3.117

5.  Development of a model of elevated intraocular pressure in rats by gene transfer of bone morphogenetic protein 2.

Authors:  Lakisha K Buie; Md Zahidul Karim; Matthew H Smith; Teresa Borrás
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-08-13       Impact factor: 4.799

Review 6.  Animal models of glucocorticoid-induced glaucoma.

Authors:  Darryl R Overby; Abbot F Clark
Journal:  Exp Eye Res       Date:  2015-06-04       Impact factor: 3.467

7.  Triamcinolone acetonide decreases outflow facility in C57BL/6 mouse eyes.

Authors:  Sandeep Kumar; Shaily Shah; Emily Rose Deutsch; Hai Michael Tang; John Danias
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-02-01       Impact factor: 4.799

8.  Little evidence for association of the glaucoma gene MYOC with open-angle glaucoma.

Authors:  Seongsoo Sohn; Wonhee Hur; Young Ran Choi; Yun Shin Chung; Chang-Seok Ki; Changwon Kee
Journal:  Br J Ophthalmol       Date:  2010-05       Impact factor: 4.638

Review 9.  Model systems for the study of steroid-induced IOP elevation.

Authors:  Ilya Rybkin; Rosana Gerometta; Gabrielle Fridman; Oscar Candia; John Danias
Journal:  Exp Eye Res       Date:  2016-07-20       Impact factor: 3.467

10.  Proteomic analysis of rat retina in a steroid-induced ocular hypertension model: potential vulnerability to oxidative stress.

Authors:  Nariko Miyara; Manabu Shinzato; Yoshito Yamashiro; Akihiro Iwamatsu; Ken-Ichi Kariya; Shoichi Sawaguchi
Journal:  Jpn J Ophthalmol       Date:  2008-04-30       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.